Can an app get teens with MS moving? new study aims to find out
NCT ID NCT04782466
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a smartphone app designed to help teens and young adults with multiple sclerosis become more physically active. The app provides coaching, activity tracking, and educational modules. Researchers will measure changes in physical activity levels, fitness, and quality of life in 56 participants aged 11-21.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Smartphone app with physical activity coaching, self-monitoring, and educational modules
What this could lead to
If it works, this could provide a practical, app-based way to help teens with MS become more active, potentially improving their well-being and reducing disease activity.
What could go wrong
This is a small, early-stage study with only 56 participants, so results may not apply to all youth with MS. The app may not lead to lasting changes in physical activity or disease outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
-
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
-
The University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States